Page 12 - Cancer

Researchers in US develop drug that marks cancer cells for elimination

The new therapy, described Sept. 12 in Cell Cancer, pulls a mutated version of the protein KRAS to the surface of cancer cells, where the drug-KRAS complex acts as an "eat me" flag

Early cancer detection with blood test may change cancer screening

Over 50 distinct cancer kinds each have a common cancer signal that new MCED tests being developed will be able to identify and pinpoint where in the body the signal originated

Joe Biden to channel Kennedy in his push for a cancer 'moonshot'

US President Joe Biden next week will highlight his plans for drastically reducing cancer deaths and boosting treatments for the disease in what he has called this generation's moonshot", the White House announced on Wednesday. Biden's speech at the John F. Kennedy Presidential Library and Museum in Boston on Monday will come on the 60th anniversary of his predecessor's speech outlining his vision for putting the first man on the moon. The White House said Biden will outline what his administration is doing to end cancer as we know it". The issue is personal for Biden, whose son Beau Biden died in 2015 of brain cancer. Biden launched the cancer moonshot the following year when serving as President Barack Obama's vice president. In February, Biden, a Democrat, set more ambitious goals for the project, including cutting the rate of cancer deaths in half in the coming 25 years and improving treatments and quality of life for those with cancer and their caregivers.

Breast cancer among men slowly on the rise & usually detected late: Doctors

The disease is now being diagnosed in relatively younger men

Cancers in adults under 50 on 'dramatic' rise globally, finds study

The incidence of cancers diagnosed before the age of 50 has dramatically increased around the world, with this rise beginning around 1990, according to a study. These early onset cancers include cancers of the breast, colon, esophagus, kidney, liver, and pancreas among others, the researchers said. Possible risk factors for early-onset cancer include alcohol consumption, sleep deprivation, smoking, obesity, and eating highly processed foods, the researchers said. While adult sleep duration has not drastically changed over the several decades, children are getting far less sleep today than they were decades ago, they said. Risk factors such as highly-processed foods, sugary beverages, obesity, type 2 diabetes, sedentary lifestyle, and alcohol consumption have all significantly increased since the 1950s, which researchers speculate has accompanied altered microbiome. "From our data, we observed something called the birth cohort effect," said Shuji Ogino, a professor at the Brigham a

European Union blocks merger of US firms in cancer screening sector

The European Union's anti-trust watchdog announced on Tuesday that it is blocking the buyout of cancer-screening company GRAIL by biotech giant Illumina in a rare move by European regulators against two US companies. Illumina is a major supplier of next-generation sequencing (NGS) systems for genetic and genomic analysis, while GRAIL is a health company developing blood tests to try to catch cancer early. Illumina announced an $8 billion acquisition of GRAIL in 2020. But the European Commission, which polices competition issues, said the buyout would have enabled and incentivised Illumina to foreclose GRAIL's rivals, who are dependent on Illumina's technology, from access to an essential input they need to develop and market their own tests. Commission Executive Vice-President Margrethe Vestager said that it is vital to preserve competition between early cancer detection test developers at this critical stage of development. As Illumina did not put forward remedies that would have .

Explained: What is the controversy around J&J's talc-based baby powder?

Johnson and Johnson (J&J) has been facing several thousand lawsuits from women who claim that they developed ovarian cancer after using the product

Deformation mechanics may be key in cancer treatment: Researchers

A team has uncovered surprising mechanical behaviors of the nucleus. For years, the nucleus within a cell was thought to be elastic like a rubber ball, deforming and snapping back into shape as the cell navigated through pores and between fibers inside the human body. Researchers have now discovered that the nucleus is more complex than originally believed, behaving more like a liquid drop than a rubber ball."The discovery that the nucleus deforms like a liquid drop calls for a fresh look at how the nuclear shape becomes abnormal in diseases like cancer," said Dr. Tanmay Lele, Unocal Professor in the Department of Biomedical Engineering.Lele, a Cancer Prevention & Research Institute of Texas (CPRIT) Scholar, is co-leading the team that uncovered the surprising mechanical behaviors of the nucleus. Their findings were published in Advanced Science in June 2022.The genetic material governing a cell's function and behavior, called the genome, is safely stored in the nucleus. Nearly .

New radiolabelling method for personalised cancer treatment revealed

TU Delft researchers have developed a new method for producing nanocarriers loaded with radioactive salts for imaging and treatment. Because the assembly of these nanocarriers is so simple, the innovation is ideal for clinical research and cancer treatment.The findings of the research were published in the journal 'Advanced Therapeutics'.Chemotherapy is a treatment meant to attack metastasised tumours, but this method unfortunately has many adverse side effects. Nano carriers made out of so-called polymer micelles are a promising, less toxic alternative to chemotherapeutic drugs. Micelles are tiny spheres that can carry around substances inside their core."Clinicians are finding more and more applications of polymer micelles already, mostly to carry chemotherapeutic drugs," co-author of the article and Associate Professor in Applied Radiation & Isotopes Antonia Denkova explained. "Their biggest advantage is that the toxicity to healthy tissue is reduced, meaning that you could ..

Anshu Jain, first non-European to head Deutsche Bank, passes away at 59

Jain recently recruited teams of traders from larger rivals to work at Cantor Fitzgerald as that firm's chief, Howard Lutnick, expanded ambitions in trading and relationships with global investors

Johnson and Johnson: Why talc-based powder will stop their sales in 2023?

After 38,000 serious allegations, Johnson and Johnson's talc-based baby powder will stop international sales from 2023. The product has already been discontinued in the US and Canada

Fashion designer Issey Miyake, who produced Jobs' turtlenecks, dies at 84

He defined an era in Japan's modern history, reaching stardom in 1970s among a generation of designers and artists who reached global fame by defining a Japanese vision that was unique from the West

Trump's son-in-law was diagnosed with thyroid cancer while in WH: Report

Jared Kushner, the son-in-law of former US President Donald Trump, was diagnosed with thyroid cancer while he was serving as a senior adviser in the White House, according to a media report

NIM inclusion of anti-cancer vaccine may start with 9-14 year olds

The inclusion of this vaccine in the NIM is a significant step in reducing cervical cancer burden among women

Cell-therapy treatment for cancer in India may come at 10% of US cost

Pharma firms and start-ups working to launch it within 2 yrs

Indian-origin woman cancer-free after experimental drug trial in UK

Jasmin David, 51, from Fallowfield in Manchester is now looking forward to celebrating her 25th wedding anniversary in September after the successful NHS trial

Gene therapy to cure leukemia at one-tenth global costs in the works

ImmunoACT, backed by Laurus Labs is testing their cancer product

Alembic Pharma gets USFDA nod for cancer treatment drug in US market

Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancers, in the American market

A cancer trial's unexpected result: Remission in every patient

The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to 'happy tears'

Breakthrough Covid infection more likely in cancer, Alzheimer's patients

Breakthrough Covid-19 cases resulting in infections, hospitalisations and deaths are significantly more likely in cancer and Alzheimer's patients, according to two new studies.